These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3412313)

  • 21. [The role of epithelial antigens in diagnosis and staging of breast cancer].
    Artamonova EV; Tupitsyn NN; Kadagidze ZG; Letiagin VP; Ermilova VD; Ognerubov NA; Panichenko AV; Riazantseva SN
    Arkh Patol; 2002; 64(6):13-5. PubMed ID: 12534220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Carcinoembryonic antigen (CEA) and mucinous-like tumor associated antigen (MAC). Statistic correlation in advanced breast carcinoma].
    Sbalzarini G; D'Agostino F; Mercantini F; Girami M; Labadini A; Pandolfi C
    Minerva Med; 1991 Dec; 82(12):811-3. PubMed ID: 1780086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibody CIBCHTB1 defining an epitope on carcinoembryonic antigen (CEA).
    Meenakshi A; Kumar NS; Vijayshanker SG
    Hum Antibodies; 2000; 9(4):223-9. PubMed ID: 11341176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V; Björklund B
    Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion].
    Kiluk MS; Rółkowski R; Zawadzki RJ; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2002 Oct; 13(76):298-301. PubMed ID: 12557435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tumor markers in human breast cancer].
    Takami H; Shikata J
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):2998-3003. PubMed ID: 3479050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer.
    Findeisen R; Albrecht S; Richter B; Deutschmann K; Zimmermann T; Distler W
    Luminescence; 2000; 15(5):283-9. PubMed ID: 11038485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Factors influencing on the prognosis in breast cancer].
    Taguchi T; Horino T; Ota J
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2043-9. PubMed ID: 2456037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunohistochemical studies with monoclonal antibodies in human mammary carcinoma tissues].
    Kasper M; Stosiek P; Karsten U
    Acta Histochem Suppl; 1988; 35():199-205. PubMed ID: 2458614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients.
    Shively JE; Spayth V; Chang FF; Metter GE; Klein L; Presant CA; Todd CW
    Cancer Res; 1982 Jun; 42(6):2506-13. PubMed ID: 7074626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation of carcinoembryonic antigen (CEA) and serum and tissue alpha-fetoprotein (AFP) in malignant tumors of the female genital tract].
    Tolino A; Di Serio C; Borruto Caracciolo G; Giamberini S; Montemagno U
    G Ital Oncol; 1989; 9(2-3):63-6. PubMed ID: 2475441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].
    Meregalli M; Antoniazzi V; Torchio G; Colombo E; Bocchi M; Sonzini E; Lino S
    Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical evaluation of tumor markers in breast cancer patients].
    Ito T; Tanaka S; Ban K; Sakai N; Oshita H; Oiwa T; Kanno A; Kashizuka T
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2917-23. PubMed ID: 3310907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoperoxidase detection of carcinoembryonic antigen in fine needle aspirates of breast carcinoma. Correlation with studies in tissue sections.
    Murthy L; Kapila K; Verma K
    Acta Cytol; 1988; 32(1):60-2. PubMed ID: 3276079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.
    Tondini C; Hayes DF; Gelman R; Henderson IC; Kufe DW
    Cancer Res; 1988 Jul; 48(14):4107-12. PubMed ID: 3164256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
    Samy N; Ragab HM; El Maksoud NA; Shaalan M
    Cancer Biomark; 2010; 6(2):63-72. PubMed ID: 20571232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of carcinoembryonic antigen test in human mammary carcinoma.
    Batabyal SK; Ghosh SN; Roy NK; Mehrotra YN; Gupta A
    Indian J Pathol Microbiol; 1987 Oct; 30(4):407-12. PubMed ID: 3507401
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
    Zheng H; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Basic and clinical aspects of tumor markers--with special reference to CEA].
    Matsuoka Y
    Rinsho Byori; 1990 Jan; 38(1):31-4. PubMed ID: 2308221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occurrence of carcinoembryonic antigen in tumor tissue and serum of breast cancer patients.
    Stratil P; Rejthar A; Lang BA; Kocent A; Pacovský Z; Matoska J
    Neoplasma; 1988; 35(1):69-76. PubMed ID: 3352839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.